HealthpointCapital
HealthpointCapital is a US-based private equity firm founded in 2002 that invests exclusively in musculoskeletal healthcare, currently holding majority stakes in IlluminOss Medical (fracture fixation), SteriCUBE (sterilization systems), and ImmersiveTouch (VR/AR surgical planning), with a focus on growing and exiting these companies to strategic acquirers.
- Company typePrivate
- Founded2002
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What HealthpointCapital does
HealthpointCapital is a New York- and San Diego-based private equity firm founded in 2002 that invests exclusively in the musculoskeletal (MSK) healthcare sector, describing itself as the leading dedicated PE firm in orthopedics. The firm takes majority stakes in emerging and established MSK companies and supports them with operating expertise, clinical and scientific advisory networks, and strategic relationships with Tier-1 acquirers including Stryker, Johnson & Johnson Medtech, Zimmer Biomet, Smith & Nephew, and CONMED. Its current active portfolio comprises three platforms: IlluminOss Medical (photodynamic, minimally invasive intramedullary fracture fixation using a light-curable liquid monomer), SteriCUBE (a patented multi-tray sterilization system that eliminates disposable blue wrap and can be stored up to 30 days), and ImmersiveTouch (a VR/AR surgical planning and navigation platform with computer-vision-generated 3D models for craniomaxillofacial, thoracic, and neurosurgery). A fourth historical holding, CrossRoads Extremity Systems, was acquired in May 2019 and exited to DePuy Synthes in February 2022 as the firm's first MSK Fund realization.
The firm generates revenue through the standard PE model: recurring management fees on committed capital under management and performance-based carried interest (typically 20%) on profitable exits. HealthpointCapital sources deals through deep industry engagement, including the Musculoskeletal New Ventures Conference (MNVC), which it has hosted for 23 consecutive years, and through partnerships such as the AAOS Investment Insights Forum (March 2026) and the Ortho Summit Investor Day. The senior team — Managing Partner Mike Mogul (former CEO of DJO Global, Group President at Stryker), Managing Director Matt Link (former President at NuVasive), Managing Director Gary Stevenson (co-founder of MB Venture Partners), Managing Director Milen Todorov (formerly UBS healthcare M&A), and Operating Partner Lisa Holt — is heavily weighted with operators from Stryker, DJO Global, NuVasive, DePuy, and UBS, providing operating bench strength that is rare among healthcare PE firms.
The firm's stated thesis is to align interests with founders, accelerate growth through operational and regulatory support, and exit to strategic acquirers; demonstrated exits include OrthoSpace (to Stryker), Blue Belt Technologies (to Smith & Nephew), BioHorizons (to Henry Schein), and CrossRoads Extremity Systems (to DePuy Synthes/J&J). The firm does not disclose fund size, AUM, or portfolio company financials, and operates within a US-only geographic footprint, with US-based limited partners as the implicit funding base.
HealthpointCapital firmographics
Firmographics- Name
- HealthpointCapital
- Legal name
- HealthpointCapital Management LLC
- Website
- http://www.healthpointcapital.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- HealthpointCapital is a US-based private equity firm founded in 2002 that invests exclusively in musculoskeletal healthcare, currently holding majority stakes in IlluminOss Medical (fracture fixation), SteriCUBE (sterilization systems), and ImmersiveTouch (VR/AR surgical planning), with a focus on growing and exiting these companies to strategic acquirers.
- Ownership category
- akta.pro rank
HealthpointCapital industry classification
Industry- Product category
- Healthcare Private Equity
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Finance Services (6199), Investment Advice (6282)
- akta.pro primary industry
- Private Equity Buyout Fund-of-Funds (FSANAGAD)
Keywords
Where HealthpointCapital is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
HealthpointCapital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Management Fees: Private equity firm generates revenue through management fees charged on assets under management, typically a percentage of committed capital.
- Carried Interest: The firm earns carried interest (typically 20%) on profits generated from successful portfolio company exits, representing the primary performance-based revenue stream for the PE firm.
Go-to-market motion1 record
Marketing channels4 records
HealthpointCapital product offering
Product offeringCore offering
HealthpointCapital is a values-based, research-driven private equity firm that provides growth capital and active operating support to innovative musculoskeletal healthcare companies, including medical device, surgical technology, and digital health firms. The firm manages dedicated Musculoskeletal Funds (MSK Fund I and MSK Fund II), acquires majority stakes in portfolio companies, and ultimately exits through sale to large strategic acquirers such as Stryker, Johnson & Johnson, and Smith & Nephew.
Product overview
HealthpointCapital is a private equity firm focused exclusively on the musculoskeletal healthcare sector. The firm's portfolio includes three active portfolio companies offering distinct medical technologies: SteriCUBE (multi-tray sterilization systems eliminating blue wrap), IlluminOss (photodynamic bone stabilization implants for fragility fractures), and ImmersiveTouch (VR/AR surgical planning software). The company also had one realized exit (CrossRoads Extremity Systems sold to DePuy Synthes).
Differentiator
Problem solved
Functional benefit
Products and services
- Musculoskeletal Fund (MSK Fund I) Dedicated private equity fund investing growth capital in musculoskeletal healthcare companies (medical device, extremities, orthopedics); provides capital, operating expertise, and exit pathway via strategic acquirers for innovative musculoskeletal healthcare companies.
- Musculoskeletal Fund II (MSK Fund II)
Quantifiable outcome
- Successfully exited OrthoSpace (to Stryker), Blue Belt Technologies (to Smith & Nephew), BioHorizons (to Henry Schein), and CrossRoads Extremity Systems (to DePuy Synthes/J&J)
Companies that use HealthpointCapital
Customer profileSegments1 record
Ideal customer profiles2 records
HealthpointCapital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
HealthpointCapital partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and flagship.
- American Academy of Orthopaedic Surgeons (AAOS)coreHealthpointCapital partnered with AAOS for the inaugural Investment Insights Forum at the AAOS 2026 Annual Meeting in New Orleans. The partnership delivers insights from investors, strategics and surgeons shaping the future of the orthopedics business.
- The Orthopaedic Summit: Evolving Techniques Course (OSET)coreHealthpointCapital co-hosted inaugural Investor Day at Ortho Summit with presentations by 21 private spine and orthopedic companies and panels featuring c-suite executives from major strategics including Zimmer Biomet, Johnson & Johnson Medtech, Smith & Nephew, and CONMED.
- DePuy Synthes (Johnson & Johnson)flagshipSuccessful exit achieved through sale of CrossRoads Extremity Systems to DePuy Synthes. CrossRoads was acquired in May 2019 and sold in February 2022 following significant revenue growth and innovation cadence.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
HealthpointCapital competitors and assessment
Company assessmentDirect peers
- Avista Capital Partners: Healthcare-dedicated private equity firm with deep sector focus across medical devices, pharmaceuticals, and healthcare services. Direct comparable as a sector-specialist PE firm investing in healthcare sub-sectors and exiting to strategic acquirers.
- Linden Capital Partners: Healthcare-focused private equity firm based in Chicago investing in middle-market healthcare companies. Direct comparable as a dedicated healthcare PE firm with operating partner model and strategic acquirer relationships.
- Frazier Healthcare Partners: Healthcare-dedicated private equity and venture firm investing across medical devices, biopharma, and healthcare services. Direct comparable given dedicated healthcare focus and operating partner value-add model.
- Ampersand Capital Partners: Life sciences and healthcare-specialist private equity firm focused on pharma services, medical devices, and diagnostics. Direct comparable as a sector-focused PE firm with operating expertise and strategic acquirer exit orientation.
- Riverside Partners: Healthcare-focused private equity firm investing in middle-market medical device and healthcare services companies. Direct comparable in dedicated healthcare PE with growth-oriented operating support.
Emerging players
- MB Venture Partners: Earlier-stage, MSK-focused venture firm previously co-founded by Gary Stevenson (now a HealthpointCapital Managing Director). Highly relevant as it operated in the same MSK niche and connected directly to HealthpointCapital's deal flow and conference ecosystem.
Broad incumbents
- Welsh, Carson, Anderson & Stowe: Large, established healthcare and technology-focused private equity firm with dedicated healthcare team. Comparable as a broader incumbent with healthcare sub-sector specialization, including medical device investments.
- KKR Health Care Strategic Growth: Growth equity platform within KKR focused on healthcare and life sciences. Comparable as a larger incumbent with healthcare PE capabilities competing for similar mid-market healthcare deals.
- Bain Capital Life Sciences: Life sciences and healthcare investment arm of Bain Capital. Comparable as a larger incumbent with dedicated healthcare investing across devices, biopharma, and services.
- TPG Capital (Healthcare): Major global private equity firm with a dedicated healthcare practice investing across medical devices, healthcare services, and life sciences. Comparable as a broad incumbent competing for similar mid-to-large healthcare deals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
HealthpointCapital social profiles
Digital presenceHealthpointCapital compliance and trust
Trust signalCompliance2 records
HealthpointCapital financial estimates
Financial estimateRevenue estimate
Valuation estimate
HealthpointCapital leadership team
Management profileNumber of profiles
Profiles9 records
HealthpointCapital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HealthpointCapital M&A and investment
M&A and investmentM&A6 records
Investments7 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HealthpointCapital
What does HealthpointCapital do?
HealthpointCapital is a values-based, research-driven private equity firm that provides growth capital and active operating support to innovative musculoskeletal healthcare companies, including medical device, surgical technology, and digital health firms. The firm manages dedicated Musculoskeletal Funds (MSK Fund I and MSK Fund II), acquires majority stakes in portfolio companies, and ultimately exits through sale to large strategic acquirers such as Stryker, Johnson & Johnson, and Smith & Nephew.
Is HealthpointCapital a public or private company?
HealthpointCapital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was HealthpointCapital founded?
HealthpointCapital was founded in 2002. It employs 11 to 50 people.
Where is HealthpointCapital based?
HealthpointCapital is headquartered in New York, United States, in the North America region.
How does HealthpointCapital make money?
Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest.
Who are HealthpointCapital's main competitors?
Direct peers on record are Avista Capital Partners, Linden Capital Partners, Frazier Healthcare Partners, Ampersand Capital Partners and Riverside Partners. MB Venture Partners is listed as an emerging player. Broad incumbents are Welsh, Carson, Anderson & Stowe, KKR Health Care Strategic Growth, Bain Capital Life Sciences and TPG Capital (Healthcare).
Does HealthpointCapital have an API?
No public API is recorded for HealthpointCapital.
What industry is HealthpointCapital in?
HealthpointCapital's product category is Healthcare Private Equity. Its primary akta.pro industry code is FSANAGAD, Private Equity Buyout Fund-of-Funds. Its NAICS code is 523940 and its SIC code is 6199.